<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34384436</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>DNA aptamer against EV-A71 VP1 protein: selection and application.</ArticleTitle><Pagination><StartPage>164</StartPage><MedlinePgn>164</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">164</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-021-01631-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Enterovirus 71 (EV-A71) is a highly infectious pathogen associated with hand, foot and mouth disease, herpangina, and various neurological complications, so it is important for the early detection and treatment of EV-A71. An aptamer is a nucleotide sequence that screened in vitro by the technology named systematic evolution of ligands by exponential enrichment technology (SELEX). Similar to antibodies, aptamers can bind to the targets with high specificity and affinity. Besides, emerging aptamers have many advantages comparing with antibodies, such as ease of synthesis and modification, having a wide variety of target materials, low manufacturing cost and easy flexibility in amending. Therefore, aptamers are promising in virus detection and anti-virus therapy.</AbstractText><AbstractText Label="METHODS">Aptamers were selected by SELEX. Specificity, affinity and second structure were used to characterize the selected aptamers. Chemiluminescence was adopted to build an aptamer-based detection method for EV-A71. Cytopathogenic effects trial, the level of intracellular EV-A71 RNA and protein expression were used to evaluate the antiviral effect of the selected aptamers.</AbstractText><AbstractText Label="RESULTS">Three DNA aptamers with high specificity and affinity for EV-A71structual protein VP1 were screened out. A rapid chemiluminutesescence aptamer biosensor for EV-A71 detection was designed out. The selected aptamers could inhibit the RNA replication and protein expression of EV-A71 in RD cells and ameliorate the cytopathogenic effects.</AbstractText><AbstractText Label="CONCLUSIONS">The aptamers against EV-A71 have the potentiality to be applied as attractive candidates used for EV-A71 detection and treatment in the future.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Xinran</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang City, Jiangsu Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou City, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang City, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang City, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Laboratory, Zhenjiang Center for Disease Control and Prevention, Zhenjiang City, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Lingxiang</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2065-0188</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang City, Jiangsu Province, China. maolingxiang@aliyun.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052157">Aptamers, Nucleotide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D052157" MajorTopicYN="Y">Aptamers, Nucleotide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aptamer</Keyword><Keyword MajorTopicYN="N">Detection</Keyword><Keyword MajorTopicYN="N">EV-A71</Keyword><Keyword MajorTopicYN="N">SELEX</Keyword><Keyword MajorTopicYN="N">Therapy</Keyword></KeywordList><CoiStatement>No&#xa0;potential&#xa0;conflict&#xa0;of&#xa0;interest&#xa0;was&#xa0;reported&#xa0;by&#xa0;the&#xa0;authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>13</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34384436</ArticleId><ArticleId IdType="pmc">PMC8359077</ArticleId><ArticleId IdType="doi">10.1186/s12985-021-01631-y</ArticleId><ArticleId IdType="pii">10.1186/s12985-021-01631-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev Vaccines. 2016;15(5):599&#x2013;606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KY. Enterovirus 71 infection and neurological complications. Korean J Pediatr. 2016;59(10):395&#x2013;401. doi: 10.3345/kjp.2016.59.10.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2016.59.10.395</ArticleId><ArticleId IdType="pmc">PMC5099286</ArticleId><ArticleId IdType="pubmed">27826325</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Xu M, Yin Z. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antivir Res. 2013;97(2):183&#x2013;194. doi: 10.1016/j.antiviral.2012.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.005</ArticleId><ArticleId IdType="pubmed">23261847</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39(2&#x2013;3):195&#x2013;205. doi: 10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, Hsieh SY, Liu CC, Chou AH, Chang JY, Wu SC, Liu SJ, Chow YH, Su IJ, Klein M. Production of EV71 vaccine candidates. Hum Vaccines Immunother. 2012;8(12):1775&#x2013;1783. doi: 10.4161/hv.21739.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.21739</ArticleId><ArticleId IdType="pmc">PMC3656065</ArticleId><ArticleId IdType="pubmed">22992566</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, Shen L, Wu J, Zou X, Gu J, Chen J, Mao L. Enterovirus A71 proteins: structure and function. Front Microbiol. 2018;9:286. doi: 10.3389/fmicb.2018.00286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00286</ArticleId><ArticleId IdType="pmc">PMC5826392</ArticleId><ArticleId IdType="pubmed">29515559</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YX, Huang YM, Li QJ, Li XY, Zhou YD, Guo F, Zhou JM, Cen S. A highly conserved amino acid in VP1 regulates maturation of enterovirus 71. PLoS Pathog. 2017;13(9):e1006625. doi: 10.1371/journal.ppat.1006625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006625</ArticleId><ArticleId IdType="pmc">PMC5634653</ArticleId><ArticleId IdType="pubmed">28938017</ArticleId></ArticleIdList></Reference><Reference><Citation>Darmostuk M, Rimpelova S, Gbelcova H, Ruml T. Current approaches in SELEX: an update to aptamer selection technology. Biotechnol Adv. 2015;33(6 Pt 2):1141&#x2013;1161. doi: 10.1016/j.biotechadv.2015.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biotechadv.2015.02.008</ArticleId><ArticleId IdType="pubmed">25708387</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, Wu J, Gu J, Shen L, Mao L. Application of aptamers in virus detection and antiviral therapy. Front Microbiol. 2019;10:1462. doi: 10.3389/fmicb.2019.01462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01462</ArticleId><ArticleId IdType="pmc">PMC6618307</ArticleId><ArticleId IdType="pubmed">31333603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, Liang Z. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccines Immunother. 2014;10(2):360&#x2013;367. doi: 10.4161/hv.27087.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho SJ, Woo HM, Kim KS, Oh JW, Jeong YJ. Novel system for detecting SARS coronavirus nucleocapsid protein using an ssDNA aptamer. J Biosci Bioeng. 2011;112(6):535&#x2013;540. doi: 10.1016/j.jbiosc.2011.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiosc.2011.08.014</ArticleId><ArticleId IdType="pmc">PMC7106535</ArticleId><ArticleId IdType="pubmed">21920814</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, Meng X, Yu Q, Xu L, Long Y, Liu B, Fang X, Zhu H. Inhibition of hepatitis C virus infection by DNA aptamer against envelope protein. Antimicrob Agents Chemother. 2013;57(10):4937&#x2013;4944. doi: 10.1128/AAC.00897-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00897-13</ArticleId><ArticleId IdType="pmc">PMC3811438</ArticleId><ArticleId IdType="pubmed">23877701</ArticleId></ArticleIdList></Reference><Reference><Citation>Percze K, Szakacs Z, Scholz E, Andras J, Szeitner Z, Kieboom CH, Ferwerda G, Jonge MI, Gyurcsanyi RE, Meszaros T. Aptamers for respiratory syncytial virus detection. Sci Rep. 2017;7:42794. doi: 10.1038/srep42794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42794</ArticleId><ArticleId IdType="pmc">PMC5318870</ArticleId><ArticleId IdType="pubmed">28220811</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo MY, Chen LJ, Jiang H, Tan L, Luo ZF, Wang YM. Detecting endotoxin with a flow cytometry-based magnetic aptasensor. Anal Biochem. 2014;466:38&#x2013;43. doi: 10.1016/j.ab.2014.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2014.08.018</ArticleId><ArticleId IdType="pubmed">25172133</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin S, Chen N, Yang X, Wang Q, Wang K, Huang J, Liu J, Zhou M. Development of dual-aptamers for constructing sandwich-type pancreatic polypeptide assay. ACS Sens. 2017;2(2):308&#x2013;315. doi: 10.1021/acssensors.6b00836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acssensors.6b00836</ArticleId><ArticleId IdType="pubmed">28723135</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z, Huang R, Li Z, He N, Wang T, Su E, Deng Y. Selection of HBsAg-specific DNA aptamers based on carboxylated magnetic nanoparticles and their application in the rapid and simple detection of hepatitis B virus infection. ACS Appl Mater Interfaces. 2015;7(21):11215&#x2013;11223. doi: 10.1021/acsami.5b01180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsami.5b01180</ArticleId><ArticleId IdType="pubmed">25970703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn DG, Jeon IJ, Kim JD, Song MS, Han SR, Lee SW, Jung H, Oh JW. RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein. Analyst. 2009;134(9):1896&#x2013;1901. doi: 10.1039/b906788d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b906788d</ArticleId><ArticleId IdType="pubmed">19684916</ArticleId></ArticleIdList></Reference><Reference><Citation>Smither SJ, Lear-Rooney C, Biggins J, Pettitt J, Lever MS, Olinger GG., Jr Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. J Virol Methods. 2013;193(2):565&#x2013;571. doi: 10.1016/j.jviromet.2013.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2013.05.015</ArticleId><ArticleId IdType="pubmed">23748121</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Feng X, Yan X, Liu K, Deng L. A DNA aptamer against influenza A virus: an effective inhibitor to the hemagglutinin-glycan interactions. Nucleic Acid Ther. 2016;26(3):166&#x2013;172. doi: 10.1089/nat.2015.0564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/nat.2015.0564</ArticleId><ArticleId IdType="pubmed">26904922</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Gu J, Shen L, Fang D, Zou X, Cao Y, Wang S, Mao L. Exosomal microRNA-155 inhibits enterovirus A71 infection by targeting PICALM. Int J Biol Sci. 2019;15(13):2925&#x2013;2935. doi: 10.7150/ijbs.36388.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.36388</ArticleId><ArticleId IdType="pmc">PMC6909958</ArticleId><ArticleId IdType="pubmed">31853228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Wu J, Shen L, Yang J, Chen J, Xu H. Enterovirus 71 transmission by exosomes establishes a productive infection in human neuroblastoma cells. Virus Genes. 2016;52(2):189&#x2013;194. doi: 10.1007/s11262-016-1292-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-016-1292-3</ArticleId><ArticleId IdType="pubmed">26837894</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong P, Li W, Li J. Applications of aptasensors in clinical diagnostics. Sensors. 2012;12(2):1181&#x2013;1193. doi: 10.3390/s120201181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s120201181</ArticleId><ArticleId IdType="pmc">PMC3304108</ArticleId><ArticleId IdType="pubmed">22438706</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao L, Zhao Q. Using fluoro modified RNA aptamers as affinity ligands on magnetic beads for sensitive thrombin detection through affinity capture and thrombin catalysis. Anal Methods. 2016;8(3):510&#x2013;516. doi: 10.1039/C5AY02665B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5AY02665B</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Liu H, Jain A, Zhang L, Liu C, Cheng K. Discovery of aptamer ligands for hepatic stellate cells using SELEX. Theranostics. 2017;7(12):2982&#x2013;2995. doi: 10.7150/thno.19374.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.19374</ArticleId><ArticleId IdType="pmc">PMC5566100</ArticleId><ArticleId IdType="pubmed">28839458</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrasiabi S, Pourhajibagher M, Raoofian R, Tabarzad M, Bahador A. Therapeutic applications of nucleic acid aptamers in microbial infections. J Biomed Sci. 2020;27(1):6. doi: 10.1186/s12929-019-0611-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0611-0</ArticleId><ArticleId IdType="pmc">PMC6941257</ArticleId><ArticleId IdType="pubmed">31900238</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G, Chen X. Aptamer-based targeted therapy. Adv Drug Deliv Rev. 2018;134:65&#x2013;78. doi: 10.1016/j.addr.2018.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2018.08.005</ArticleId><ArticleId IdType="pmc">PMC6239901</ArticleId><ArticleId IdType="pubmed">30125604</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>